Article contributed by: Ed Ikeguchi, CEO AiCure The jobs of study sites in clinical research are difficult. Keeping patients engaged throughout the course of a trial is always challenging, particularly now during the COVID-19 pandemic. While numerous remote technologies exist to facilitate virtual patient visits or to monitor patient’s medication adherence and symptoms, they cannot […]
Featured Article
How Natural Language Processing Unlocks the Full Healthcare and Patient Journey
By Andrea
Contributed to PharmaLeaders by Authors: By Ana Bargo, M.S.; Jeannine Cain, MSHI, RHIA, CPHI; Shannon Fee, B.A.; Mark Yap, FNP-C In 2016, a major transformation occurred in how we evaluate clinical data for real-world effectiveness. The FDA signed into law the 21st Century Cures Act, which impacted the Real-World Evidence Program in the U.S. It […]
White Papers
Schedule Your Personalized Marketing Technology Workshop
PharmaLeaders is pleased to provide our subscribers with a special offer from our webinar partner and presenter, Collaborative Marketing Solutions … FREE Download
Automation of Process Control within the Pharmaceutical Industry
While most pharmaceutical businesses have adopted process automation in one format or another, the technology has evolved considerably over the past … FREE Download
Industry News
Novartis, GSK team up for $3.6m genetic diversity research in Africa
Novartis and GSK have agreed to provide £2.8m ($3.6m) for the Africa Genomic Research Approach for Diversity and Optimizing Therapeutics (GRADIENT) project (Project Africa GRADIENT), over the next The post Novartis, GSK team up for $3.6m genetic diversity research in Africa appeared first on … [Read More...]
Cure Genetics, Boehringer to develop AAV vectors for gene therapy
The companies will leverage Cure Genetics’ VELP platform to develop the vectors. Under the partnership, Boehringer’s experience in disease biology and gene therapy development will be combined with The post Cure Genetics, Boehringer to develop AAV vectors for gene therapy appeared first … [Read More...]
Etana to launch Innovent Biologics’ cancer drug BYVASDA in Indonesia
Etana now has the right to sell BYVASDA in the country and in return, Innovent Biologics will receive milestones for the development and commercialisation along with double-digit royalties The post Etana to launch Innovent Biologics’ cancer drug BYVASDA in Indonesia appeared first on Pharmaceutical … [Read More...]
Thermo Fisher Scientific acquires viral vector business from Novasep for $875m
The viral vector manufacturing arm of Novasep offers contract manufacturing services for vaccines and therapies to biotechnology and biopharma companies. Established over 20 years ago, the business has The post Thermo Fisher Scientific acquires viral vector business from Novasep for $875m appeared … [Read More...]